Revance Replaces Lidocaine with Mepivacaine in RHA Filler Line
Revance announces the U.S. launch of the Teoxane RHA Collection with mepivacaine, replacing lidocaine as the anesthetic in its dermal filler products.
Revance announces the U.S. launch of the Teoxane RHA Collection with mepivacaine, replacing lidocaine as the anesthetic in its dermal filler products.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.